SUPPLEMENTARY EXPERIMENTAL PROCEDURES

Cell cycle synchronisation
For G1/S synchronisation, HeLa cells were cultured in the presence of 2.5mM thymidine (Sigma) for 16 hours, washed twice with Phosphate Buffer Saline (PBS), once with medium and cultured in fresh medium for 8 hours. 2.5mM thymidine was then added to cells for further 16 hours, washed twice with PBS, once with medium and cultured into fresh medium. siRNA oligos were transfected between the first and second thymidine block. To trap cells in prometaphase, 100ng/ml nocodazole (MP Biomedicals) was added seven hours after the second release from thymidine block.
To enrich the G2 and M cell populations, cells were cultured in 2.5mM thymidine for 16 hours, washed twice with PBS, once with medium and cultured in fresh medium for 4 hours. Cells were then cultured in the presence of nocodazole for 16 hours.
Chemical Inhibitors
The following inhibitors were used: Casein Kinase II Inhibitor VIII (Merck) at 2.5µM, MLN4924 (Cell signalling) at 2µM, MG132 (Sigma) at 10µM and cycloheximide (CHX) (Sigma Aldrich) at 50µg/ml.
Plasmids generation
Cyclin F and cyclin F fragments plasmids have been previously described (D'Angiolella et al., 2010) . Cyclin F mutants where generated by site directed mutagenesis on the pcDNA3 Flag-cyclin F backbone. Cyclin F WT and mutants were isolated from pcDNA3 and inserted into pBabe by sub-cloning. Flag-tagged β-TrCP1 (Fbxw1), β-TrCP2 (Fbxw11), Fbxw2, Fbxw5, Fbxw7, Cdh1, Cdc20 and MycUbiquitin were described before (D'Angiolella et al., 2010) .
Transient plasmid expression
For transient plasmid transfection, HEK293T cells were seeded the previous day prior to transfection using the reagent "PEI Max", Polyethylenimine HCl Max (Polysciences).
Stable cell lines generation
For retrovirus production, a pBabe-puro (Addgene, 1764) retroviral vector containing the gene of interest was co-transfected into HEK293T with the pUMVC Gag/Pol vector (Addgene, 8449) packaging vector and pCMV-VSV-G (Addgene, 8454) envelope-encoding vector. For transduction, cells were seeded at 30% confluency. 24 hours later, fresh medium was added along with the virus-containing media at a 1:1 ratio, in the presence of 8µg/mL polybrene, and incubated for 16 hours. This was followed by 2µg/mL puromycin selection for 72 hours. Expression of the protein of interest was confirmed by Western blot.
For CRISPR cyclin F KnockOut (KO) cell lines, sgCCNF (5'-CTCAAGATGGTCAGGTTTCG-3') was cloned into pSpCas9 (BB) pX330 vector (Addgene plasmid ID 42230) as previously described (Bauer et al., 2015) . Single cell clones were sorted and cyclin F loss was identified by Western blot. were incubated with secondary antibodies for 1 hour at room temperature, washed with PBS-T and exposed to ECL (Thermo Scientific).
Antibodies
Ubiquitylation assay
EV, Flag-tagged Cyclin F or HA-tagged β-TrCP2 were co-transfected with 1µg Myctagged ubiquitin. At twenty four hours post transfection, cells were incubated with MG132 for four hours prior to lysis. Anti-Flag M2 agarose beads were used to immunoprecipitate cyclin F. The beads were washed four times in lysis buffer.
Samples were then incubated at 95°C for 10 minutes, resolved by SDS-PAGE and analysed by immunoblotting.
In vitro ubiquitylation assay
In vitro ubiquitylation assay was previously described (Dorrello et al., 2006) . Briefly, cyclin F ubiquitylation was performed in a volume of 10 µl containing 50 mM Tris pH 7.6, 5 mM MgCl 2 , 0.6 mM DTT, 2 mM ATP, 2 µl in vitro transcribed/translated unlabeled β-TrCP1, 1.5 ng/µl E1 (Boston Biochem), 10 ng/µl Ubc3, 10 ng/µl Ubc5, 2.5 µg/µl ubiquitin (Sigma-Aldrich), 1 µM ubiquitin aldehyde (Sigma-Aldrich), 180 nM CK2α (Invitrogen), 1 µl 35 S-methionine-labelled in vitro transcribed/translated cyclin F as substrate. The reactions were incubated at 30°C for 30 minutes and analyzed by SDS-PAGE and autoradiography.
Time-lapse microscopy
HeLa cells were synchronised to G1/S phase by double thymidine block, released into fresh medium and transferred to Nikon Ti-E microscope with the Nikon Perfect Focus System (PFS). Imaging was undertaken with a 20x 0.75NA objective with the cells maintained in a constant atmosphere of 5% CO2 at 37 o C throughout. Images were acquired as a 3x3 montage with a Hamamatsu Flash4 sCMOS detector at 5 minutes intervals for a total of 24 hours. Tracking of cells undergoing division was undertaken using the TrackMate plugin for Fiji. For detection a Difference of Gaussian (DoG) filter was utilised with a high threshold value to ensure only cells undergoing division were detected.
Tandem affinity purification and mass spectrometry
Analysis of immunoprecipitated endogenous cyclin F material was essentially performed as described previously (Adam et al., 2011) . In brief, immunoprecipitated cyclin F was separated by SDS-PAGE, visualized by Coomassie staining, and gel bands were excised and destained overnight in 50% methanol, 5% acetic acid in water. Proteins were reduced with 10 mM dithiothreitol and then alkylated using 20 mM iodoacetamide. Proteins were digested with 1 µg elastase or trypsin in 50 mM ammonium bicarbonate overnight at 37 °C, and resulting peptides were extracted from the gel with 50% acetonitrile, 5% acetic acid in water. Peptide material was analysed on an Acquity nano UPLC system (Waters) equipped with a 25 cm C18 column, 1.7 µm particle size (Waters) online coupled to an LTQ Orbitrap Velos (Thermo Scientific) as described (Adam et al., 2011) . Raw MS data was processed and analysed using PEAKS software as described previously (Davis et al., 2017) . The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD010737
and 10.6019/PXD010737. Database: http://www.ebi.ac.uk/pride
Peptide cross-linking
The following peptides: 694-GKDVTTSGYSSVST-707 (nophos), 694-GKDVTTpSpGYSSpVST-707 (phos), 694-GKDVTTSpGYSSpVST-707 (Δ699), 694-GKDVTTpSGYSSpVST-707 (Δ700), 694-GKDVTTpSpGYSSVST-707 (Δ704)
were conjugated to CNBr-activated Sepharose-4B according to the manufacturer's instruction.
In vitro kinase assay
HEK293T cells were transfected with Flag-cyclin F WT for twenty four hours followed by immunoprecipitation with ANTI-FLAG® M2 Affinity Gel (SigmaAldrich). Immunopurified Flag-cyclin F was first de-phosphorylated by treatment with lambda phosphatase (New England Biolabs) and then incubated at 30°C for 25 minutes with 0.2 mM ATP and the indicated kinases in a 10 µl reaction of kinase buffer (25 mM Tris pH 7.5, 10 mM MgCl2, 2 mM DTT, 5 mM β-glycerophosphate,
mM sodium orthovanadate). Reaction products were stopped with Laemmli
Sample buffer and then subjected to immunoblotting. For sequential in vitro kinase assay, immunopurified Flag-cyclin F was subjected to a first phosphorylation reaction (25 mins) with the indicated purified kinases. Samples were then washed three times in lysis buffer (50 mM Tris-HCl pH 7.5, 250 mM NaCl, 0.1% Triton X-100, 1 mM EGTA) to remove the first kinase and twice in kinase buffer. Samples were then subjected to a second phosphorylation reaction as described above. 
